Comparative efficacy of expanded hemodialysis and online hemodiafiltration: a systematic review and meta-analysis
Aktas O. Akhmedullin R. Abbay A. Narin A.E. Yanilmaz M.S. Genc C. Gaipov A. Covic A. Kanbay M.
November 2025Springer Science and Business Media B.V.
International Urology and Nephrology
2025#57Issue 113761 - 3772 pp.
Background and aim: The comparison between online hemodiafiltration (online HDF) and expanded hemodialysis (HDx) remains undetermined. This systematic review and meta-analysis were conducted to provide comparative evidence on the molecule clearance, efficacy, and all-cause mortality of HDx versus online HDF in patients with end-stage kidney disease (ESKD). Materials and methods: A comprehensive search was conducted up to September 10, 2024, using various electronic databases PubMed, Cochrane Library, Scopus, Web of Science, and Ovid MEDLINE with adherence to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Risk ratios (RR) for binary outcomes and standardized mean differences (Hedge’s g) were used for continuous outcomes. Results: The meta-analysis included eight studies, consisting of 614 patients in total. No statistical difference in all-cause mortality was found between HDx and online HDF (RR 0.97; 95% Cl 0.62–1.53, p = 0.91, I2 = 0%). Online HDF revealed a decrease in β2-microglobulin clearance (Hedges’s g = − 0.61, 95% CI − 1.04 to − 0.18, p = 0.01), with no differences in creatinine, phosphate, and urea clearance. Prolactin clearance favored online HDF (Hedge’s g = − 1.49, 95% Cl − 3.36 to 0.37, p = 0.12) but the pooled estimate remained insignificant, with high heterogeneity (I2 = 90.87%). Conclusion: Overall, both modalities are found to be effective, but online HDF revealed superior efficacy with potential advantages in middle-molecule clearance. Further standardized, randomized, and high-quality trials are required not only to confirm these findings but also to address the substantial heterogeneity found in the clearance of prolactin, myoglobulin, and albumin loss. Registration: PROSPERO registration number: CRD42024622632.
Expanded hemodialysis , Hemodialysis , Medium cut-off membrane , Online hemodiafiltration
Text of the article Перейти на текст статьи
Department of Medicine, Faculty of Medicine, Koç University, Istanbul, Turkey
Department of Medicine, School of Medicine, Nazarbayev University, Astana, Kazakhstan
Nephrology Clinic, Dialysis, and Renal Transplant Center-“C.I. Parhon” University Hospital, Iasi, Romania
Department of Internal Medicine, Division of Nephrology, Koc University School of Medicine, Istanbul, 34010, Turkey
Department of Medicine
Department of Medicine
Nephrology Clinic
Department of Internal Medicine
10 лет помогаем публиковать статьи Международный издатель
Книга Публикация научной статьи Волощук 2026 Book Publication of a scientific article 2026